Written by: Madeline Barron
Editors: Christian Greenhill, Kristen Loesel, and Peijin Han
We are currently at war with antibiotic-resistant bacteria—and it’s not looking good. In 2019, the Center for Disease Control and Prevention (CDC) estimated that 2.8 million antibiotic-resistant infections occur in the United States each year, resulting in 35,000 deaths and billions of dollars in healthcare costs. This is over 28% higher than the approximated number of infections and deaths in 2013. Yet, despite the rise in antibiotic-resistant infections, antibiotics remain our primary weapon for combatting bacterial pathogens; if they stop working, infections that were once easily controlled could become untreatable. Thus, there is a critical need to look beyond our arsenal of antibiotics for new methods to treat bacterial infections.
Enter: Nanoparticles.Continue reading “Nanoparticles may be tiny, but they are the next big thing for fighting antibiotic-resistant bacteria”